Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 10 - 100Exact Company Size |
Primary Industry | 325411 Medicinal & Botanical Manufacturing |
Additional NAICS Codes | 325413 In-Vitro Diagnostic Substance Manufacturing |
Address | 12117 Bee Caves Road Building Three Suite 100 Austin, TX 78738 |
Aspira Women's Health | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Aspira Women's Health P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
OVASUITE Providing reagent sample testing and diagnostic services for others for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing medical and scientific research information; providing medical and scientific research information in the field of cancer detection and clinical trials; providing medical and scientific research information in the field of ovarian cancer detection and clinical trials; providing medical and scientific research information in the field of breast cancer detection and clinical trials; providing medical and scientific research services in the field of biomarker testing and cancer screening; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the field of ovarian cancer treatment and diagnosis; medical and scientific research services in the field of breast treatment and diagnosis; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the fields of women's health, genetics, gynecology and cancer; scientific research consulting in the field of genetics; product development in the fields of women's health, genetics, gynecology, diagnostics and cancer; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; consulting services in the fields of laboratory testing and diagnostics; providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; platform as a service (PAAS) featuring computer software platforms for diagnostic testing in the field of women's health; software as a service (SAAS) services featuring software for diagnostic testing; software as a service (SAAS) services featuring software for cancer diagnostic testing; software as a service (SAAS) services featuring software for genetic testing; software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing | 09/08/2022 |
OVAWATCH Medical testing for diagnostic or treatment purposes in the field of oncology; medical testing for diagnostic or treatment purposes in the field of gynecology; medical diagnosis of cancer | 07/30/2021 |
OVA360 Medical testing for diagnostic or treatment purposes in the field of oncology; Medical testing for diagnostic or treatment purposes in the field of ovarian cancer; Medical testing for diagnostic or treatment purposes in the field of breast cancer; medical testing for diagnostic or treatment purposes in the field of gynecology and women's health; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer | 03/31/2021 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
XYMOGEN | Orlando, FL | 100 |
AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
NUTRITION FORMULATORS | Miramar, FL | 36 |
RTPR | Cabot, AR | 33 |
INTEGRATED BOTANICS | Fort Worth, TX | 29 |
COSMAX NBT USA | Garland, TX | 29 |
CJB INDUSTRIES | Valdosta, GA | 28 |
ALTERNATIVE LABORATORIES | Naples, FL | 28 |
S&B PHARMA | Azusa, CA | 28 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
FAGRON HOLDING USA | Austin, TX | 100 |
MOLECULAR TEMPLATES | Austin, TX | 13 |
PREMIER RESEARCH LABS | Austin, TX | 11 |
ASPIRA WOMEN'S HEALTH | Austin, TX | 4 |
ORGANICARE NATURE'S SCIENCE | Austin, TX | 1 |
SPEEDX | Austin, TX | 0 |
Company | Revenue ($ MM) |
---|---|
|